Chaoju Eye Care Holdings Limited Stock

Equities

2219

KYG2047K1094

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. 04:08:07 2024-05-09 am EDT 5-day change 1st Jan Change
3.88 HKD +1.31% Intraday chart for Chaoju Eye Care Holdings Limited +1.57% -12.22%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 1.63B 225M 1.76B Sales 2025 * 1.89B 262M 2.04B Capitalization 2.39B 330M 2.58B
Net income 2024 * 277M 38.34M 300M Net income 2025 * 343M 47.47M 371M EV / Sales 2024 * 1.47 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 1.26 x
P/E ratio 2024 *
8.93 x
P/E ratio 2025 *
7.26 x
Employees 2,597
Yield 2024 *
4.52%
Yield 2025 *
5.08%
Free-Float 48.47%
More Fundamentals * Assessed data
Dynamic Chart
Chaoju Eye Care Unit Buys Structured Deposits Worth 150 Million Yuan MT
Chaoju Eye Care Arms Ink Five Tenancy Deals in Inner Mongolia MT
Chaoju Eye Care Holdings Limited Announces Special Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024 CI
Chaoju Eye Care Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024 CI
Chaoju Eye Care Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Chaoju Eye Care Unit Invests 200 Million Yuan in Bank of China’s Structured Deposit Product MT
Chaoju Eye Care Holdings Limited commences an Equity Buyback for 70,762,500 shares, representing 10% of its issued share capital, under the authorization approved on June 6, 2023. CI
Chaoju Eye Care Holding Units Complete Purchase of 97% Stake in Beijing Eye Hospital MT
Chaoju Eye Care Plans Up to HK$100 Million Share Buyback; Shares Rise 5% MT
Chaoju Eye Care Holdings Limited Announces Resignation of Mr. Ke Xian as Non-Executive Director CI
Chaoju Eye Care Holdings Subsidiary Purchases 180 Million Yuan Worth of Structured Deposit Products MT
Chaoju Eye Care Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Chaoju Eye Care Sees Up to 52% Jump in H1 Profit MT
Chaoju Eye Care Holdings Limited Provides Consolidated Earning Guidance for the Six Months Ended June 30, 2023 CI
Chaoju Eye Care Holdings Limited Announces Change of Principal Place of Business in Hong Kong CI
More news
1 day+1.31%
1 week+1.57%
Current month+0.78%
1 month-1.02%
3 months+6.59%
6 months-1.52%
Current year-12.22%
More quotes
1 week
3.83
Extreme 3.83
4.09
1 month
3.57
Extreme 3.57
4.09
Current year
3.50
Extreme 3.5
4.57
1 year
3.50
Extreme 3.5
5.64
3 years
2.60
Extreme 2.6
17.80
5 years
2.60
Extreme 2.6
17.80
10 years
2.60
Extreme 2.6
17.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 20-05-18
Director of Finance/CFO 42 18-02-28
Chief Operating Officer 54 16-12-31
Members of the board TitleAgeSince
Chief Executive Officer 61 20-05-18
Director/Board Member 62 -
Director/Board Member 57 -
More insiders
Date Price Change Volume
24-05-09 3.88 +1.31% 772 000
24-05-08 3.83 -3.04% 415,000
24-05-07 3.95 -1.25% 698,500
24-05-06 4 +1.01% 881,000
24-05-03 3.96 +3.66% 770,000

Delayed Quote Hong Kong S.E., May 09, 2024 at 04:08 am EDT

More quotes
Chaoju Eye Care Holdings Limited is a China-based company principally engage in the provision of ophthalmic services and eye care services through hospitals and optical clinics. The Company operates its businesses through two segments. The Consumer Ophthalmic Services segment provides refractive correction (including presbyopia correction), myopia control and provides optical products and services. The Basic Ophthalmic Services segment provides treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases and pediatric eye diseases, which may be covered by public health insurance programs. The Company mainly conducts its businesses in the domestic market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.541 CNY
Average target price
5.922 CNY
Spread / Average Target
+67.26%
Consensus

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW